CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
25.93
1.48%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-4.63)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 26.35
Open 26.37
1-Year Change -9.63%
Day's Range 25.96 - 26.53
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 26.35 -0.15 -0.57% 26.50 26.76 26.29
Dec 16, 2024 26.54 -0.63 -2.32% 27.17 27.39 26.54
Dec 13, 2024 27.39 0.12 0.44% 27.27 27.58 27.02
Dec 12, 2024 27.55 0.56 2.07% 26.99 27.68 26.99
Dec 11, 2024 27.24 -0.26 -0.95% 27.50 27.60 27.18
Dec 10, 2024 27.53 -0.44 -1.57% 27.97 27.97 27.40
Dec 9, 2024 27.80 -0.03 -0.11% 27.83 28.55 27.69
Dec 6, 2024 27.94 -0.12 -0.43% 28.06 28.38 27.72
Dec 5, 2024 28.38 -0.32 -1.11% 28.70 28.83 28.22
Dec 4, 2024 28.84 0.93 3.33% 27.91 28.86 27.91
Dec 3, 2024 28.28 -0.01 -0.04% 28.29 28.61 28.09
Dec 2, 2024 28.44 0.23 0.82% 28.21 28.59 27.98
Nov 29, 2024 28.43 -0.04 -0.14% 28.47 28.63 28.17
Nov 27, 2024 28.67 0.47 1.67% 28.20 28.88 28.20
Nov 26, 2024 28.31 0.14 0.50% 28.17 28.38 27.82
Nov 25, 2024 28.34 0.12 0.43% 28.22 28.87 28.22
Nov 22, 2024 28.01 1.09 4.05% 26.92 28.06 26.92
Nov 21, 2024 27.02 0.16 0.60% 26.86 27.28 26.60
Nov 20, 2024 27.10 0.00 0.00% 27.10 27.24 26.74
Nov 19, 2024 27.06 0.57 2.15% 26.49 27.20 25.97

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Perrigo Company profile

About Perrigo Company PLC

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S) and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies, and e-commerce channels.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Perrigo Company PLC revenues increased 1% to $4.14B. Net loss before extraordinary items totaled $130.9M vs. income of $44.2M. Revenues reflect CSCI segment increase of 4% to $1.45B, CSCA segment remaining flat at $2.69B, Europe segment increase of 3% to $1.39B. Net loss reflects CSCA segment income decrease of 56% to $206.5M. Dividend per share increased from $0.90 to $0.96.

Equity composition

Common Stock no Par, 08/11, 200M auth., 92,797,375 issd. Insiders own 7.05%. IPO: 10/93, 13Mshares @ $31 by J.P. Morgan Securities Inc. 8/93, 2-for-1 stock split. FY'02 & Q's are restated. FY'03 & '04 Summ. Q's reflect the reclassification. FY'04 Q's are reclassified.

Industry: Pharmaceuticals (NEC)

The Sharp Building
Hogan Place
DUBLIN
DUBLIN
IE

People also watch

BTC/USD

104,922.50 Price
-1.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

ETH/USD

3,884.58 Price
-1.330% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,990.10 Price
0.000% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,637.23 Price
-0.340% 1D Chg, %
Long position overnight fee -0.0083%
Short position overnight fee 0.0001%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading